IVIG Criteria and Indications for Kawasaki Disease in Pediatric Patients

Diagnosis and Treatment

The American Heart Association recommends that all children diagnosed with Kawasaki disease should receive IVIG 2 g/kg as a single infusion, regardless of risk stratification scores, to prevent coronary artery aneurysms 1, 2
Children with classic Kawasaki disease should be treated immediately with IVIG if they have fever ≥5 days and at least 4 of 5 principal clinical features, including bilateral nonpurulent conjunctivitis, oral mucosal changes, polymorphous rash, extremity changes, and cervical lymphadenopathy 3, 4, 5
The American Heart Association emphasizes that treatment should be administered within the first 10 days of fever onset, ideally between days 5-10, to reduce coronary artery aneurysm risk from 25% to less than 5% 6, 5

Incomplete Kawasaki disease is particularly critical in children under 5 years, especially infants under 1 year, who have the highest rates of coronary aneurysms if untreated 1, 7, 3
Consider incomplete Kawasaki disease and proceed with laboratory testing when a child has fever ≥5 days and only 2-3 principal clinical features 1, 7

Laboratory criteria supporting treatment include CRP ≥3.0 mg/dL and/or ESR elevated, as well as additional supportive findings such as albumin ≤3.5 g/dL, anemia for age, elevated ALT, platelet count ≥450,000/mm³ after day 7, WBC ≥15,000/mm³, and sterile pyuria 1, 5, 3

For infants under 6 months with fever ≥7 days, laboratory evidence of systemic inflammation, and no alternative explanation for fever, perform echocardiography and strongly consider IVIG treatment 7, 1
IVIG should still be administered to children presenting after day 10 if they have persistent fever without alternative explanation, elevated inflammatory markers, or coronary artery aneurysms with ongoing systemic inflammation 5

The standard treatment protocol includes IVIG 2 g/kg as a single infusion over 10-12 hours, high-dose aspirin 80-100 mg/kg/day divided into 4 doses until afebrile for 48-72 hours, and then transition to low-dose aspirin 3-5 mg/kg/day as single daily dose 5, 3

Common misdiagnoses in children under 5 years include fever with unilateral cervical lymphadenopathy mistaken for bacterial lymphadenitis, sterile pyuria misinterpreted as partially treated UTI, and young infants with fever, rash, and CSF pleocytosis misdiagnosed as viral meningitis 4, 1, 7
Risk stratification scores should not determine whether to treat in North America, as all diagnosed patients receive IVIG due to the poor positive predictive value of these scores 1, 2, 8

Mandatory follow-up requirements include deferring measles and varicella immunizations for 11 months after high-dose IVIG, annual influenza vaccination for children on long-term aspirin therapy, and avoiding ibuprofen in children taking aspirin 5, 3

If fever persists or recurs ≥36 hours after completing initial IVIG, consider a second dose of IVIG 2 g/kg or second-line options such as IV methylprednisolone 20-30 mg/kg for 3 days or infliximab 5 mg/kg 5, 3, 9